At each assessment, PrediCare allows the physician to act by one of the following scenarios:
- If no progression is predicted between the current and next assessment- continue treatment as usual under the current line;
- If a progression event between the current and next assessment is predicted - consider switching to the next line treatment, before a major deterioration in the patient’s state takes place
PrediCareTM allows a switch to the next-line treatment, earlier than recommended by the SOC, therefore leading to improved late-stage treatment navigation. The use of PrediCare is expected to result in extended overall survival, satisfying the goal of all cancer therapeutics for all stake-holders.